Lingguizhugan decoction protects PC12 cells against Aβ25-35-induced oxidative stress and neuroinflammation by modulating NF-κB/Mapk signaling pathways
Bibliographic Data
| ID | 14726745 |
|---|---|
| Authors | Jing Han (0000-0003-3442-8454, Shenyang Pharmaceutical University), Haotian Zhang (0009-0008-1415-6221, Shenyang Pharmaceutical University), Yu Zhang (0000-0002-0059-270X, Shenyang Pharmaceutical University), Zan Zhang (0000-0002-4911-1620, Shenyang Pharmaceutical University), Maomao Yu (Shenyang Pharmaceutical University), Sijie Wang (0000-0002-4948-0514, Shenyang Pharmaceutical University), Fei Han (0009-0004-2081-2521, Shenyang Pharmaceutical University, corresponding author) |
| Year | 2022 |
| Volume | 292 |
| Pages | 115194 |
| Publication date | 2022-06-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2022.115194 |
| PMID | 35304276 |
| OpenAlex | W4221031372 |
| Language | EN |
| Citations received | 3 |
| References cited | 25 |
Apoptosis · Biology · Hyperphosphorylation · Inflammation · Kinase · MAPK/ERK pathway · MTT assay · Neuroinflammation · Neuroprotection · Neurotoxicity · NF-κB · Oxidative stress · p38 mitogen-activated protein kinases · Signal transduction · Toxicity · Viability assay · Western blot · Alzheimer's disease research and treatments · Bone Metabolism and Diseases · Chemistry · Pharmacological Effects of Medicinal Plants · Biochemistry · Cell Biology · Immunology · Molecular Biology · Pharmacology
Chinese medicine Linggui Zhugan formula protects against diabetic kidney disease in close association with inhibition of proteinase 3-mediated podocyte apoptosis in mice
Interdisciplinary strategies for deciphering the mechanisms of Chinese medicines
Targeting chemokine-receptor mediated molecular signaling by ethnopharmacological approaches
| Unique citing works | 3 |
|---|---|
| Citations per year | 1 |
| Citation span | 2023 - 2024 (2) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 3 |